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Helicobacter pylori is considered the most prevalent infectious agent among humans, and it causes gastric inflam-
mation, gastroduodenal ulcers, and a risk of gastric cancer. We performed a genomewide linkage analysis among
Senegalese siblings phenotyped for H. pylori–reactive serum immunoglobulin G. A multipoint LOD score of 3.1
was obtained at IFNGR1, the gene that encodes chain 1 of the interferon-g (IFN-g) receptor. Sequencing of IFNGR1
revealed 556CrT, H318P, and L450P variants, which were found to be associated with high antibody concen-
trations. The inclusion of these in the linkage analysis raised the LOD score to 4.2. The variants were more prevalent
in Africans than in whites. Our findings indicate that IFN-g signaling plays an essential role in human H. pylori
infection, and they contribute to an explanation of the observations of high prevalences and relatively low path-
ogenicity of H. pylori in Africa. Moreover, they provide further support for the value of genomewide linkage studies
in the analysis of susceptibility to infection and other complex genetic traits.
Introduction
Helicobacter pylori is considered the most common in-
fectious agent among humans worldwide. In the United
States and Europe, 25%–50% of the population are in-
fected, and prevalences in developing countries reach
70%–90%, with almost all individuals acquiring the in-
fection before the age of 10 years (Dunn et al. 1997).
Approximately 10%–20% of infected individuals de-
velop disease, such as gastritis or gastroduodenal ul-
cer, and have an increased risk of gastric cancer (Blaser
1998).
Several lines of evidence indicate a genetic influence
on the susceptibility to H. pylori. Twin studies have
shown a substantial genetic component (Malaty et al.
1994). Furthermore, evidence of ethnic differences was
obtained by comparing North Americans of different
ancestries (Graham et al. 1991). Finally, inbred mouse
strains show varying degrees of susceptibility to exper-
imental Helicobacter infection (Sawai et al. 1999).
H. pylori–reactive serum immunoglobulin G (IgG)
concentrations, using whole bacterial lysates as antigen,
have been found to be a reliable tool for defining the
infection state of humans (Evans et al. 1989; Marchil-
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don et al. 1999). Accordingly, they have been widely
used in genetic and epidemiological studies (Evans et al.
1989; Graham et al. 1991; Malaty et al. 1994; Mar-
childon et al. 1999). Here, we present a genomewide
linkage analysis of H. pylori infection, defined by re-
active serum IgG, in Senegalese sibships.
Material and Methods
Study Group
The protocol was approved by the ethics committee
of the Board of Physicians of Hamburg. Participants
belonged to a study group analyzed for genetic factors
controlling the intensity of infection with Schistosoma
mansoni (Mu¨ller-Myhsok et al. 1997). They were re-
cruited in the village of Ndombo, near the town of Rich-
ard Toll, in northern Senegal. The group comprised 10
families with 2 siblings, 11 with 3, 10 with 4, and 4
with 5.
Phenotyping
Serum levels of IgG antibodies to H. pylori were de-
termined, as described elsewhere (Nilius et al. 2001),
using a commercially available ELISA (Synelisa, Phar-
macia, Upjohn, and Amersham Biosciences), which ap-
plies a composite of recombinant and whole-cell–lysate
antigens. Serum levels of IgG antibody to phosphoryl-
choline were determined as reported elsewhere (Schen-
kein et al. 2001).
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Table 1
PCR Primer Pairs Used in Sequencing of the IFNGR1 Gene
Exon Sense (5′r3′) Antisense (5′r3′)
Product Size
(bp)
Pr1/2a TGATTTGACACTGAATTGCTG CCTGCTCACACCCTGCATGAC 652
Pr3/4a TGATCTGGCTGATAATACCTC ATCGGCTTGACCAAGAACTAC 525
1 GCACGACGCCGTGCTCACTGC AACCACGGAGCCCCAGTCTCG 473
2 TATACATATCTGGGCAATGTG GAAGGCTGATGAAAGAACACAG 301
3 ACTTTCTCTGGCGTCTCCATC ATGCTCAACCTGTACTGACTC 466
4 GTCCTGCTTTAGAACAACCAG AATGTATTCACATGGTCAGTG 499
5 CAGATGCATAGTATCGTGCTG TCTAAGGAATGGAACTAATGC 511
6 ATTGCTATCTAAGACAGATAC TGATTGATGGCAGGTGACATC 436
7 GGTGGTCCATTACTTCAGACC ACAATTTCTGAGATCATAATC 791
a Pr1/2 and Pr3/4 are primer pairs for the proximal and distal parts of the 5′ region of IFNGR1.
Primers were derived from the Homo sapiens chromosome 6 working draft sequence segment
(NT_025741.8), published by the National Center for Biotechnology Information Annotation Project.
Linkage Analysis
The distribution of IgG values (U/ml) was substan-
tially skewed to the left. Therefore, the values were log
transformed to approximate normality. The genome
screen was performed, as described elsewhere (Adams
et al. 1998), using the human genome screening set, ver-
sion 6, developed by J. L. Weber. The complete set con-
sisted of 373 markers (86% tri- or tetranucleotide re-
peats), with an average heterozygosity of 76% and an
average spacing of 10 cM (Invitrogen). Genotypes were
determined using GeneScan and GenoTyper software
(Applied Biosystems), yielding export files containing al-
lele tables for each individual marker. Inheritance of al-
leles was verified by use of the PedCheck program
(O’Connell and Weeks 1998). A quantitative-trait anal-
ysis was performed by applying a Haseman-Elston sta-
tistic, as implemented in GeneHunter2 (Kruglyak and
Lander 1995). Allele frequencies were estimated in the
study group, using the DownFreq program (Terwilliger
1995). Map order and distances of markers were ob-
tained from the Marshfield map (Center for Medical
Genetics, Marshfield Medical Research Foundation;
Broman et al. 1998) and were verified by calculating the
order with our own marker data, using the Crimap pro-
gram (Lander and Green 1987), with a threshold for
linkage of LODp 3.0. A quantitative transmission/dis-
equilibrium test was performed with the QTDT program
as described elsewhere (Abecasis et al. 2000).
Sequencing and SNP Analysis
All seven exons of IFNGR1 (MIM 107470) and 1,045
nt of the 5′-region of the gene were amplified from ge-
nomic DNA (table 1). Annealing temperatures were
54C for all reactions, except those primed by Pr3/Pr4
and exon 5–sense/exon 5–antisense, for which they were
56C and 55C, respectively. PCR products were se-
quenced bidirectionally on an ABI 3100 sequencer (Ap-
plied Biosystems; EMBL and National Center for Bio-
technology Information Nucleotide databases). SNPs
were analyzed by dynamic allele-specific hybridization
with fluorescence resonance energy transfer, in a
LightCycler (Hoffmann–La Roche) (table 2). Annealing
temperatures were 54C for all reactions, except the one
analyzing –56CrT, for which it was 58C.
Results
Study Group and Phenotype
A total of 111 siblings aged 5 to 60 years, who were
from 35 Senegalese nuclear families and comprised 143
sib pairs, were phenotyped for H. pylori infection, using
serum IgG reactive to major H. pylori antigens. Sixty-
three percent of the study group were positive, with
no significant age dependence. Serum levels of anti–
phosphorylcholine IgG, which is produced in reaction
to ubiquitous dental-plaque bacteria (Schenkein et al.
2001), were measured as a control and were found not
to be correlated with levels of anti–H. pylori IgG (rp
, ).0.12 Pp .2
Linkage Analysis
A genomewide linkage analysis yielded a peak that
covered ∼90 cM on the long arm of chromosome 6,
with a maximum multipoint LOD score of 2.3 at marker
position D6S1009 (fig. 1). Because D6S1009 is located
!1 cM from the IFNGR1 gene that encodes chain 1 of
the interferon-g (IFN-g) receptor and because IFN-g has
been implicated in host defense against Helicobacter in-
fection (Sawai et al. 1999; Kamradt et al. 2000), an
additional marker, FA1, located in intron 6 of IFNGR1
(Altare et al. 1998), was included in the analysis. This
raised the LOD score to 3.1 (fig. 2b).
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Table 2
Primer Pairs of the IFNGR1 Variants with Anchor and Sensor Used in LightCycler Assay







a For each variant, the second nucleotide sequence represents the sensor.
b For each variant, the second nucleotide sequence represents the anchor.
Figure 1 Genomewide linkage analysis of 143 sib pairs for the intensity of H. pylori infection, as defined by serum concentrations of H.
pylori–reactive IgG.
Analysis of Polymorphisms
All seven exons and 1,045 nt of the 5′ flanking region
of the IFNGR1 gene were sequenced in 10 siblings with
extreme phenotypes from five families. Furthermore, ex-
ons 1 and 7 and the 5′ flanking region were sequenced
in 20 additional siblings. Three variants (611GrA,
527GrA, and –56CrT) were identified in the up-
stream region. Variant 611GrA was found in all but
4 of the 60 chromosomes studied, and 527GrA was
found in only 6 of them; neither of these two variants
showed evidence of an association with the phenotype,
and they were not studied further. Variant 56CrT
was found in approximately half of the chromo-
somes; 29 homozygous and 55 heterozygous carriers
of the variant had higher levels of anti–H. pylori IgG
than did the remaining 27 wild-type siblings (mean
 SD log U/ml, log U/ml, and1.33 0.44 1.33 0.49
log U/ml, respectively).1.07 0.41
In addition to the upstream variants, 1004ArC and
1400TrC exchanges were found in exon 7 of IFNGR1,
resulting in replacements of histidine 318 and leucine
450 by proline residues (H318P and L450P, respec-
tively). Among the 111 siblings studied, 14 carriers of
H318P and 3 carriers of L450P were identified; both
groups had higher anti–H. pylori IgG concentrations
than the rest (for H318P, mean  SD log1.52 0.52
U/ml vs. log U/ml; and for L450P, mean 1.23 0.46
SD log U/ml vs. log U/ml,1.51 0.90 1.26 0.46
respectively).
The variants were subjected to a quantitative trans-
mission/disequilibrium test in 111 parent-child trios.
L450P and H318P were too rare to be evaluated;
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Figure 2 Multipoint LOD scores on chromosome 6q. a, Detailed profile of the multipoint LOD scores on chromosome 6q. b,Change in
multipoint LOD scores when STR marker FA1, which is located in intron 6 of IFNGR1 (Altare et al. 1998), is included. c, Change in multipoint
LOD scores when IFNGR1 variants –56TrC, H318P, and L450P are included as additional markers. The increase in LOD score can be explained
by the combined markers becoming successively more informative, as indicated by an increment in information content from 0.73 to 0.84 and
0.94 (Kruglyak and Lander 1995).
Table 3
Frequencies of IFNGR1 Variants in Unselected
Individuals
VARIANT
% AFFECTED CHROMOSOMES IN
African Subjects White Subjects
56CrT 47 36
1004ArC (H318P) 6 0
1400TrC (L450P) 1 0
NOTE.—For the three variants combined, the difference
between African and white chromosomes is significant
( ).P ! .02
56CrT was positively associated with high anti–H.
pylori IgG concentrations ( ). When –56CrT,Pp .03
H318P, and L450P were included in the linkage analysis,
the maximum LOD score increased to 4.2 (fig. 2c).
Frequencies in Unselected Individuals
The frequencies of56CrT, H318P, and L450P were
assessed in chromosomes of 100 unrelated individuals
from the Senegalese study population and from 100 un-
related members of a German volunteer group (table 3).
H318P and L450P were found in the Senegalese sample
only, and56CrT appeared to be more frequent among
the Senegalese than among German sample.
Discussion
As the key mediators of the T helper-1 (Th1) lymphocyte
response, IFN-g and its receptor are part of an important
signaling system in the immune response to pathogens
(Shtrichman and Samuel 2001). With regard to H. py-
lori, clinical studies have shown that the human immune
response in the gastric mucosa is dominated by Th1 cells,
which produce IFN-g (D’Elios et al. 1997). In addition,
studies in the mouse model of H. felis revealed that
IFN-g is involved in the pathogenesis of gastritis and
in immunoprotection (Sawai et al. 1999; Kamradt et al.
2000).
Here, we show that high levels of circulating anti–H.
pylori IgG are linked and associated with promoter and
structural polymorphisms of IFNGR1. Anti–H. pylori
IgG levels had elsewhere been shown to be a reliable
indicator of H. pylori infection (Evans et al. 1989; Mar-
childon et al. 1999). Since the concentrations of anti-
bodies against H. pylori may also reflect antibody pro-
duction per se, which could be expected to be influenced
by IFN-g signaling, they were compared with levels of
an antibody to ubiquitous dental-plaque bacteria, but
no correlation was found. Therefore, we believe that it
is not antibody production but the course of H. pylori
infection that is reflected by the phenotype of anti–H.
pylori IgG used here and that was found to be influenced
by IFNGR1 polymorphisms.
We have not yet performed functional studies; there-
fore, we can only speculate about functional implica-
tions. The 56CrT variant affects a major transcrip-
tional initiation site of IFNGR1 (Merlin et al. 1997),
which suggests that it influences transcription. H318P
is located in the intracellular domain of IFNGR1, be-
tween the binding site for janus kinase (JAK) 1 at amino
acid positions 266–269 and a tyrosine residue at po-
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sition 440, which is phosphorylated in the process of
signal transduction by JAK1 in conjunction with JAK2
(Bach et al. 1997). L450P lies in close proximity to the
phosphorylation site. Both variants introduce a proline
residue, which may cause substantial structural altera-
tions by changing the direction of the polypeptide back-
bone. Thus, they might affect the accessibility of Y440
to phosphorylation by JAKs and, thereby, influence
IFNGR1 signal transduction.
It is also unclear whether 56CrT and the other
variants cause a gain or loss of IFNGR1 function.
Circumstantial evidence argues in favor of a loss:
Clinical and epidemiological findings in humans, as
well as experimental studies in mice, have indicated
that serum antibody levels reflect Helicobacter infec-
tion and not immunoprotection (Blanchard et al.
1999); in addition, studies in the mouse model have
shown that IFN-g contributes to protection and clear-
ance of the infection (Sawai et al. 1999; Kamradt et al.
2000). Therefore, since –56CrT was associated with
high levels of anti–H. pylori antibodies, it may be con-
cluded that the variant was associated with high sus-
ceptibility to H. pylori infection, which suggests that it
causes a loss of IFNGR1 function. This presumption
requires experimental validation.
Nevertheless, the reduced frequencies of the IFNGR1
variants found among whites would further explain the
observation that, in some African countries, the occur-
rences of peptic ulcer and gastric cancer are remarkably
low when compared with the high H. pylori prevalences
that are found (Holcombe 1992; Mitchell et al. 2002).
This observation prompted studies in the murine model,
revealing that the Th1 response and gastritis caused by
H. felis were ameliorated by helminth coinfection,
which were interpreted to show that the pathology due
to H. pylori may in Africa be mitigated because of fre-
quent helminth co-infections (Fox et al. 2000). In con-
junction with the experimental findings that IFN-g sig-
naling contributes to both clearance and pathology of
Helicobacter infection (Sawai et al. 1999; Kamradt et
al. 2000), our data provide some evidence suggesting
that IFNGR1 variants might also contribute to reduced
clearance and mitigated gastric pathology of H. pylori
in African populations.
Previous studies on the human genetics of infection
have revealed a crucial role for IFN-g signaling in the
immune defense, specifically against mycobacteria (Du-
puis et al. 2000). Severe and atypical childhood my-
cobacterial diseases, classified as Mendelian suscep-
tibility to mycobacteria (McKusick 1998), were found to
be associated with rare mutations of IFNGR1 and
other components of the IFN-g signaling pathway,
which strongly inhibit signal transduction. The var-
iant56CrT is common and presumably causes milder
forms of functional impairment. Such polymorphisms
have already been postulated to exist and to be involved
in the susceptibility to classical mycobacterial diseases,
which, like H. pylori infections, affect hundreds of mil-
lions of humans worldwide (Dupuis et al. 2000). That
additional variants of the IFN-g signaling pathway were
identified by a genomewide linkage analysis provides
further proof of principle for the value of genomewide
approaches in the analysis of susceptibility to infection
and other complex genetic traits.
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